Invention Grant
- Patent Title: PD-1/PD-L1 inhibitors
-
Application No.: US16891880Application Date: 2020-06-03
-
Publication No.: US11555029B2Publication Date: 2023-01-17
- Inventor: Evangelos Aktoudianakis , Aesop Cho , Zhimin Du , Michael Graupe , Lateshkumar Thakorlal Lad , Paulo A. Machicao Tello , Jonathan William Medley , Samuel E. Metobo , Prasenjit Kumar Mukherjee , Devan Naduthambi , Eric Q. Parkhill , Barton W. Phillips , Scott Preston Simonovich , Neil H. Squires , Peiyuan Wang , William J. Watkins , Jie Xu , Kin Shing Yang , Christopher Allen Ziebenhaus
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: C07D403/14
- IPC: C07D403/14 ; A61P31/20 ; A61P35/02 ; A61K31/496 ; C07D519/00 ; C07D241/20 ; C07D487/10 ; C07D405/14 ; C07D487/08 ; A61K31/497 ; C07D491/107 ; C07D241/18 ; A61P35/00 ; C07K16/28
Abstract:
Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
Public/Granted literature
- US20210053946A1 PD-1/PD-L1 INHIBITORS Public/Granted day:2021-02-25
Information query
